ChristineLKemptonMDMSc
Hematology • Atlanta, GAClotting Disorder, Hemophilia & Bleeding Disorder
Professor, Department of Hematology and Medical Oncology
Dr. Kempton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1365 Clifton Rd NE
Atlanta, GA 30322Phone+1 404-778-1900
Education & Training
University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2001 - 2004
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1997 - 2000
Mayo Clinic College of MedicineClass of 1997
Certifications & Licensure
OR State Medical License 1998 - Present
GA State Medical License 2005 - 2025
NC State Medical License 2001 - 2005
Clinical Trials
- Inhibitor Development in Patients With Hemophilia A Undergoing Surgery Start of enrollment: 2011 Nov 01
- Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B Start of enrollment: 2013 Feb 11
- Enoxaparin Dosing in Obesity Start of enrollment: 2013 Mar 01
Publications & Presentations
PubMed
- 16 citationsEvaluating international Haemophilia Joint Health Score (HJHS) results combined with expert opinion : Options for a shorter HJHSIsolde A R Kuijlaars, Janjaap van der Net, Brian M. Feldman, Magnus Aspdahl, Melanie Bladen
Haemophilia. 2020-10-15 - 17 citationsEffect of emicizumab prophylaxis on bone and joint health markers in people with haemophilia A without factor VIII inhibitors in the HAVEN 3 study.Anna Kiialainen, Markus Niggli, Christine L Kempton, Giancarlo Castaman, Tiffany Chang
Haemophilia. 2022-11-01 - 6 citationsEfficacy of emicizumab is maintained throughout dosing intervals for bleed prophylaxis.Steven W Pipe, Ben Trzaskoma, Miranda Minhas, Michaela Lehle, Richard H Ko
Research and Practice in Thrombosis and Haemostasis. 2023-02-01
Journal Articles
- Emicizumab Prophylaxis in Patients Who Have Hemophilia A Without InhibitorsChristine Kempton, Gallia G Levy, Michael U Callaghan, The New England Journal of Medicine
Abstracts/Posters
- Bone and Joint Health Markers in Persons with Hemophilia A (PwHA) Treated with Emicizumab in HAVEN 3Christine L. Kempton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- All-Cause and Inhibitor-Related Mortality in Non-Severe Hemophilia _ Patients in the United StatesChristine L. Kempton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Validation of Instrument to Assess Hemophilia-Related Distress61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Hematologic Emergencies2019 ACP Internal Medicine Meeting, Philadelphia - 4/12/2019
- Hemophilia: A Disease in Transition60th American Society of Hematology Annual Meeting - 12/2/2018
Authored Content
- 4 Ways I Fight BurnoutJune 2024
Press Mentions
Gene Therapy Reduced Risk of Excessive Bleeding for People with Hemophilia B, Early Trial Data SuggestsJuly 22nd, 2022
Gift from Hemophilia of Georgia Establishes Newly Renovated Bleeding and Clotting Disorders Center at EmorySeptember 13th, 2018
ASH 2016 – Saturday, December 3December 3rd, 2015- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
